Article Information
History
- September 28, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jenny L. Olson1,*,
- Gisell Castillo1,
- Amelia Palumbo1,
- Megan Harrison2,3,
- Ruth Singleton3,
- Manoj M. Lalu1,5,6,7,
- Dean A. Fergusson1,7,8,
- Alain Stintzi9,
- David R. Mack2,3,4 and
- Justin Presseau1,7,10
- 1Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
- 2Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada
- 3Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
- 4Children’s Hospital of Eastern Ontario Inflammatory Bowel Disease Centre, Ottawa, Ontario, Canada
- 5Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada
- 6Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
- 7School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
- 8Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
- 9Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada
- 10Department of Psychology, University of Ottawa, Ottawa, Ontario, Canada
- ↵*Corresponding Author Email: jolson{at}ohri.ca
Posted September 28, 2023.
A qualitative evaluation of treatment fidelity alongside a pilot trial of a novel therapy for pediatric IBD
